These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28052785)

  • 21. [Therapy with interferon plus ribavirin in hemodialysis patient with PCR-positive viral hepatitis C].
    Arambarri M; Fernández Lucas M; Echarri R; Teruel JL; Alarcón C; Merino JL; Ortuño J
    Nefrologia; 2004; 24 Suppl 3():39-42. PubMed ID: 15219067
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Hepatitis C infections in dialyzed patients].
    Podlasin RB
    Przegl Epidemiol; 2005; 59(2):541-7. PubMed ID: 16190565
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of hepatitis C virus infection (HCV) after renal transplantation: implications for HCV-positive dialysis patients awaiting a kidney transplant.
    Kamar N; Ribes D; Izopet J; Rostaing L
    Transplantation; 2006 Oct; 82(7):853-6. PubMed ID: 17038897
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Outbreak of hepatitis C virus infections at an outpatient hemodialysis facility: the importance of infection control competencies.
    Rao AK; Luckman E; Wise ME; MacCannell T; Blythe D; Lin Y; Xia G; Drobeniuc J; Noble-Wang J; Arduino MJ; Thompson ND; Patel PR; Wilson LE
    Nephrol Nurs J; 2013; 40(2):101-10, 164; quiz 111. PubMed ID: 23785746
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Occult hepatitis C virus infection in dialysis patients: does it need special attention?
    Rezaee-Zavareh MS; Ramezani-Binabaj M; Einollahi B
    Saudi J Kidney Dis Transpl; 2015 Mar; 26(2):368-9. PubMed ID: 25758893
    [No Abstract]   [Full Text] [Related]  

  • 26. Drugs for hepatitis C.
    Med Lett Drugs Ther; 2012 Oct; 54(1401):81-2. PubMed ID: 23059420
    [No Abstract]   [Full Text] [Related]  

  • 27. [Investigation of hepatitis B and hepatitis C virus infections by serological and molecular methods in hemodialysis patients].
    Dağlar D; Ergani A; Demirbakan H; Ozhak Baysan B; Ongüt G; Koçak H; Oğünç D; Akbaş H; Yıldırım B; Colak D
    Mikrobiyol Bul; 2014 Jan; 48(1):143-50. PubMed ID: 24506725
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diagnostic discordance for hepatitis C virus infection in hemodialysis: correlations with clinical and laboratory features.
    Stefanidis I; Liakopoulos V; Rigopoulou EI; Dalekos GN
    Am J Kidney Dis; 2005 Nov; 46(5):992-3; author reply 993. PubMed ID: 16253745
    [No Abstract]   [Full Text] [Related]  

  • 29. [Viral hepatitis in hemodialysis and renal transplantation patients].
    Pol S; Legendre C
    Nephrologie; 1994; 15(3):191-5. PubMed ID: 7969710
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distribution of HCV genotypes in patients with end-stage renal disease according to type of dialysis treatment.
    Selcuk H; Kanbay M; Korkmaz M; Gur G; Akcay A; Arslan H; Ozdemir N; Yilmaz U; Boyacioglu S
    Dig Dis Sci; 2006 Aug; 51(8):1420-5. PubMed ID: 16868830
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Dialysis-membrane-dependent reduction and adsorption of circulating hepatitis C virus during hemodialysis.
    Mizuno M; Higuchi T; Yanai M; Kanmatsuse K; Esumi M
    Nephron; 2002 Jun; 91(2):235-42. PubMed ID: 12053059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Patients with human immunodeficiency virus infection in the hemodialysis unit. How vulnerable are the caregivers?
    Gilbert DN; Bennett W
    Arch Intern Med; 1995 Aug 7-21; 155(15):1575-6. PubMed ID: 7618978
    [No Abstract]   [Full Text] [Related]  

  • 33. High incidence of hepatitis C virus antibodies in hemodialysis patients.
    Machida J; Yamaguchi K; Ueda S; Yoshida M; Kusumoto Y; Nishimura Y; Futami G; Ishii T; Watanabe T; Takatsuki K
    Nephron; 1992; 60(1):117-8. PubMed ID: 1310800
    [No Abstract]   [Full Text] [Related]  

  • 34. [Prevalence of hepatitis C virus infection among chronic hemodialysis patients].
    Tuyuguchi M; Saitou M; Kukita K; Kawamura A
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):319-22. PubMed ID: 15359812
    [No Abstract]   [Full Text] [Related]  

  • 35. Similar HCV viral load levels and genotype distribution among end-stage renal disease patients on hemodialysis and HCV-infected patients with normal renal function.
    Azevedo HA; Villela-Nogueira CA; Perez RM; Segadas-Soares JA; Takahashi C; Gaburo N; Pessoa I; Coelho HS
    J Nephrol; 2007; 20(5):609-16. PubMed ID: 17918148
    [TBL] [Abstract][Full Text] [Related]  

  • 36. National surveillance of dialysis-associated diseases in the United States, 2002.
    Finelli L; Miller JT; Tokars JI; Alter MJ; Arduino MJ
    Semin Dial; 2005; 18(1):52-61. PubMed ID: 15663766
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatitis C Virus Outbreaks in Hemodialysis Centers: A Continuing Problem.
    Weber DJ; Rutala WA; Fried MW
    Infect Control Hosp Epidemiol; 2016 Feb; 37(2):140-2. PubMed ID: 26813313
    [No Abstract]   [Full Text] [Related]  

  • 38. Antiviral triple therapy with boceprevir in a chronic hepatitis C haemodialysis patient awaiting kidney re-transplantation.
    Knapstein J; Galle PR; Zimmermann T
    Dig Liver Dis; 2014 Jan; 46(1):88-9. PubMed ID: 24054768
    [No Abstract]   [Full Text] [Related]  

  • 39. Epidemiology, surveillance, and prevention of hepatitis C virus infections in hemodialysis patients.
    Patel PR; Thompson ND; Kallen AJ; Arduino MJ
    Am J Kidney Dis; 2010 Aug; 56(2):371-8. PubMed ID: 20570422
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatitis B virus infection and the dialysis patient.
    Fabrizi F; Messa P; Martin P
    Semin Dial; 2008; 21(5):440-6. PubMed ID: 18397202
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.